Evidence map›Paper›PMID 24587013›Full record

Observational studyPloS one2014

Plasma D-dimer predicts short-term poor outcome after acute ischemic stroke.

Xiao-Ying Yang, Shan Gao, Jie Ding, Yan Chen, Xing-Sheng Zhou, Jing-E Wang

RetractedAbstract readObservational StudyRetracted Publication
In one paragraph

Observational study in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Prognostic Hemostasis Biomarkers in Acute Ischemic Stroke.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Xiao-Ying YangDepartment of Clinical Laboratory, Shanghai Jiao Tong University, Affiliated the Sixth People Hospital Fengxian Branch, Shanghai, P. R. China.
Shan GaoDepartment of Neurology, Shanghai Jiao Tong University, Affiliated the Sixth People Hospital Fengxian Branch, Shanghai, P. R. China.
Jie DingDepartment of Neurology, Tianjin Union Medicine Center, Tianjin, P. R. China.
Yan ChenDepartment of Neurology, Shanghai Jiao Tong University, Affiliated the Sixth People Hospital Fengxian Branch, Shanghai, P. R. China.
Xing-Sheng ZhouDepartment of Neurology, Shanghai Jiao Tong University, Affiliated the Sixth People Hospital Fengxian Branch, Shanghai, P. R. China.
Jing-E WangDepartment of Neurology, Shanghai Jiao Tong University, Affiliated the Sixth People Hospital Fengxian Branch, Shanghai, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHaemostatic biomarkers associated with poor outcome in acute ischemic stroke (AIS). The objective of the study was to evaluate the predictive value of plasma D-dimer (D-D) on functional outcome at 90-day follow-up from stroke onset.

methodsWe conducted a prospective, observational cohort study in the emergency department and enrolled 220 patients with AIS. Plasma D-D concentrations, determined by a particle-enhanced, immunoturbidimetric assay, were measured. Each patient's medical record was reviewed, and demographic, clinical, laboratory and neuroimaging information was abstracted.

resultsThere was a positive correlation between levels of D-D and the NIHSS (r = 0.361, p<0.001), and the infarct volume (r = 0.449, p<0.001). In the 69 patients with an unfavorable functional outcome, D-D levels were higher compared with those in patients with a favorable outcome [3.24(IQR, 2.18-4.60)mg/L vs 0.88(IQR, 0.35-1.77) mg/L; p<0.001]. After adjusting for all other significant outcome predictors, D-D level remained an independent predictor for unfavorable functional outcome and mortality with an odds ratio of 2.18 (95% CI, 1.55-2.83), 3.22 (95% CI, 2.05-6.43); respectively.

conclusionsD-D levels are a useful tool to predict outcome and mortality 90-day after acute ischemic stroke and have a potential to assist clinicians.

Indexed as

Fibrin Fibrinogen Degradation ProductsBiomarkersBrain IschemiaCohort StudiesHumansMagnetic Resonance ImagingProspective StudiesStrokeBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment D

Identifiers

PMID24587013
PMCPMC3933671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.